NCT01709318View on ClinicalTrials.gov

A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012)

PHASE2CompletedINTERVENTIONAL

Enrollment

666

Participants

Timeline

Start Date

December 12, 2012

Primary Completion Date

October 22, 2013

Study Completion Date

October 22, 2013

Conditions

Contraception

Interventions

DRUG

Nomegestrol acetate (NOMAC)

Daily release of 500, 700, or 900 μg.

DRUG

Etonogestrel (ENG)

Daily release of 75, 100, 120 or 125 μg

DRUG

Ethinyl estradiol (EE)

Daily release of 15 μg

DRUG

Estradiol (E2)

Daily release of 300 μg

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT01709318 - A Dose-Finding Study to Evaluate Ovarian Function and Vaginal Bleeding in Next Generation Rings (P06109/MK-8175A/MK-8342B-012) | Biotech Hunter | Biotech Hunter